Nonpharmacologic stroke prevention in atrial fibrillation

Orhan Onalan1, Ilan Lashevsky, Adel Hamad

  • 1Sunnybrook & Women's College Health Sciences Centre, Arrhythmia Services, Division of Cardiology, 2075 Bayview Avenue, B327, Toronto, Ontario, M4N 3M5, Canada. orhan.onalan@sw.ca

Insights

Non-pharmacologic stroke prevention for atrial fibrillation (AF) includes surgical or catheter-based left atrial appendage exclusion. These methods offer alternatives when oral anticoagulation is not feasible.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Surgery

Background:

  • Atrial fibrillation (AF) significantly increases stroke risk, a leading cause of death and disability.
  • Oral anticoagulation is effective but underutilized due to various limiting factors.
  • Non-pharmacologic strategies are explored for stroke prevention in AF patients.

Purpose of the Study:

  • To review the current status of non-pharmacologic methods for stroke prevention in atrial fibrillation.
  • To discuss surgical and percutaneous approaches for left atrial appendage exclusion.

Main Methods:

  • Review of current literature on non-pharmacologic stroke prevention in AF.
  • Discussion of surgical exclusion of the left atrial appendage.
  • Evaluation of emerging minimally invasive and percutaneous left atrial appendage exclusion techniques.

Main Results:

  • Surgical left atrial appendage exclusion is a routine procedure during mitral valve surgery.
  • Minimally invasive and percutaneous left atrial appendage exclusion methods are under evaluation in ongoing trials.
  • These non-pharmacologic methods present attractive alternatives for stroke prophylaxis in AF.

Conclusions:

  • Non-pharmacologic interventions, particularly left atrial appendage exclusion, are vital for stroke prevention in atrial fibrillation.
  • Further evaluation of minimally invasive and percutaneous techniques is ongoing.
  • These approaches aim to mitigate stroke risk in patients with AF where anticoagulation is contraindicated or limited.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...